Phase 1/2 clinical trial for OTO-313 in tinnitus patients

Trial Profile

Phase 1/2 clinical trial for OTO-313 in tinnitus patients

Planning
Phase of Trial: Phase I/II

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Gacyclidine (Primary)
  • Indications Tinnitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Mar 2018 New trial record
    • 08 Mar 2018 According to Otonomy media release, company expects to initiate trial the first half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top